SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Charles Butler, the company’s vice president of investor relations and corporate communications, will present at the JMP Securities 7th Annual Healthcare Conference at 9:30 a.m. EDT / 6:30 a.m. PDT on Friday, July 13, 2012, in New York. During the presentation, Mr. Butler will discuss the company’s development program and plans for cabozantinib, and review the most recent publicly available data for the compound. He will also provide a general business update.
